AU-15506

N/A

Report date: 2023/11/06 16:17:16
NME

Base Information

Drug NameAU-15506
Drug Alias NameAU-15506
ClassificationOther
Mechanisms of ActionCyclin-dependent kinase 12 inhibitorsCyclin-dependent kinase 13 inhibitors
TargetsCyclin-dependent kinase 12Cyclin-dependent kinase 13
Therapy Area/IndicationsAdenocarcinoma of Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurigene Discovery Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAurigene Discovery Technologies Ltd
Inactive CompaniesN/A
Active IndicationsAdenocarcinoma of Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A